Physiology and Clinical Relevance of Enlarged Perivascular Spaces in the Aging Brain

Corey W Bown1, Roxana O Carare1, Matthew S Schrag1

  • 1From Vanderbilt Memory and Alzheimer's Center (C.W.B., M.S.S., A.L.J.) and Department of Neurology (C.W.B., M.S.S., A.L.J.), Vanderbilt University Medical Center; Vanderbilt Brain Institute (C.W.B., M.S.S., A.L.J.), Vanderbilt University, Nashville, TN; and Department of Medicine (R.O.C.), University of Southampton, Hampshire, UK.

Neurology
|November 23, 2021
PubMed

Insights

Enlarged perivascular spaces (ePVS) are linked to cognitive issues and may result from arterial stiffening. Understanding ePVS is crucial for developing treatments for small vessel disease and Alzheimer disease.

Area of Science:

  • Neuroscience
  • Cerebrovascular Biology
  • Radiology

Background:

  • Perivascular spaces (PVS) are fluid-filled brain compartments crucial for fluid transport.
  • Enlarged PVS (ePVS) are pathological findings on MRI, potentially impacting cognition.
  • Arterial stiffening and protein aggregation are implicated in ePVS development.

Purpose of the Study:

  • To comprehensively review the clinical consequences, anatomy, fluid dynamics, physiology, risk factors, and quantification of ePVS.
  • To present competing theories on PVS physiology.
  • To examine associations between ePVS and other small vessel disease markers.

Main Methods:

  • Literature review and synthesis of existing research on ePVS.
  • Description of in vivo quantification techniques for ePVS.
  • Analysis of theoretical models of PVS physiology.

Main Results:

  • ePVS are associated with cognitive impairment.
  • Arterial stiffening and protein aggregation are potential drivers of ePVS.
  • ePVS are a marker of small vessel disease, with higher burden in Alzheimer disease.

Conclusions:

  • A thorough understanding of ePVS is essential for developing prevention and treatment strategies for neurological disorders.
  • ePVS represent a significant area of research in small vessel disease and neurodegenerative conditions.
  • Further research into ePVS mechanisms and associations is warranted.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.9K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
316
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
14
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
10
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
100
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
23